SAN JOSE, Calif., Jan. 21, 2014 /PRNewswire/ -- Xilinx, Inc. (Nasdaq: XLNX) today announced third quarter fiscal 2014 sales of $587 million, down 2% from the prior quarter and up 15% from the same quarter of the prior fiscal year. Third quarter fiscal 2014 net income was $176 million or $0.61 per diluted share; including the reversal of a litigation reserve with a net impact of $19 million, or $0.06 per diluted share.

(Logo: http://photos.prnewswire.com/prnh/20020822/XLNXLOGO)

The Xilinx Board of Directors announced a quarterly cash dividend of $0.25 per outstanding share of common stock, payable on February 27, 2014 to all stockholders of record at the close of business on February 6, 2014.

Additional third quarter comparisons are represented in the charts below:



    GAAP                                              Growth
     Results                                           Rates
    (In
     millions,
     except
     EPS)

                 Q3           Q2           Q3                      Y-T-Y

               FY 2014      FY 2014      FY 2013         Q-T-Q
               -------      -------      -------         -----

    Net
     revenues        $586.8       $598.9       $509.8          -2%       15%

    Operating
     income          $202.7       $163.8       $120.8          24%       68%

    Net income       $175.9       $141.5       $103.6          24%       70%

    Diluted
     earnings
     per share        $0.61        $0.49        $0.38          24%       61%

"Sales from Xilinx's 28nm products were $100 million in the December quarter, driven by particularly strong and broad-based Kintex(TM)-7 sales. Sales from the Zynq(TM)-7000 product family were also strong during the quarter, more than doubling sequentially, as key designs in wireless communication, industrial and aerospace and defense applications commenced production," said Moshe Gavrielov, Xilinx President and Chief Executive Officer. "The phenomenal success of our 28nm product families has driven Xilinx PLD share gains for the second consecutive calendar year."



    Net
     Revenues
     by
     Geography:

                Percentages                  Growth
                                             Rates

                    Q3            Q2          Q3

                  FY 2014       FY 2014     FY 2013     Q-T-Q     Y-T-Y
                  -------       -------     -------     -----     -----

    North
     America                29%         31%         32%       -9%        5%

    Asia
     Pacific                40%         38%         34%        3%       36%

    Europe                  22%         22%         24%       -5%        4%

    Japan                    9%          9%         10%        6%        5%



    Net
     Revenues
     by End
     Market:

                    Percentages                 Growth Rates

                        Q3            Q2             Q3

                      FY 2014       FY 2014        FY 2013       Q-T-Q     Y-T-Y
                      -------       -------        -------       -----     -----

     Communications
     & Data
     Center                     44%         43%              47%        0%        9%

    Industrial,
     Aerospace &
     Defense                    37%         38%              36%       -5%       18%

    Broadcast,
     Consumer &
     Automotive                 16%         16%              15%       -3%       22%

    Other                        3%          3%               2%        9%       40%



    Net Revenues
     by Product:

                 Percentages                  Growth
                                              Rates

                     Q3            Q2          Q3

                   FY 2014       FY 2014     FY 2013     Q-T-Q     Y-T-Y
                   -------       -------     -------     -----     -----

    New                      38%         36%         25%        5%       79%

    Mainstream               33%         34%         41%       -5%      -10%

    Base                     26%         27%         30%       -7%        0%

    Support                   3%          3%          4%       -5%       -7%

Products are classified as follows:

New products: Virtex®?7, Kintex?7, Artix(TM)-7, Zynq-7000, Virtex?6, Spartan(TM)?6 products
Mainstream products: Virtex?5, Spartan?3 and CoolRunner(TM)?II products
Base products: Virtex?4, Virtex?II, Virtex?E, Virtex, Spartan-II, Spartan, CoolRunner and XC9500 products
Support products: Configuration solutions, HardWire, Software & Support/Services



    Key Statistics:
    (Dollars in millions)

                                        Q3                  Q2           Q3

                                      FY 2014             FY 2014      FY 2013
                                      -------             -------      -------


    Annual
     Return
     on
     Equity
     (%)*                                       20                  19           17


    Operating
     Cash Flow                                $216                $255         $123


     Depreciation
     Expense                                   $14                 $14          $14


    Capital
     Expenditures                              $11                  $8           $8


    Combined
     Inventory
     Days                                      114                 102          131


    Revenue
     Turns
     (%)                                        52                  54           58


       *Return on equity calculation: Annualized net income/average
        equities, including temporary equity

Highlights - December Quarter Fiscal 2014




    --  Xilinx shipped the industry's first 20nm product in November 2013,
        continuing to execute on an aggressive rollout of its All Programmable
        UltraScale(TM) portfolio. The UltraScale product portfolio delivers the
        industry's only ASIC-class programmable architecture and extends
        Xilinx's market leading Kintex, and Virtex FPGA and 3D IC families. When
        combined with Vivado(TM) and the recently introduced UltraFast(TM)
        design methodology, Ultrascale devices enable next generation smarter
        systems such as 400G OTN, WCDMA Radio, and Intelligence Surveillance and
        Reconnaissance and high performance computing applications for the data
        center.
    --  Xilinx announced a record breaking 4.4M logic cell device, more than
        doubling its industry leading highest capacity Virtex-7 device. This is
        Xilinx's second generation Stacked Silicon Interconnect technology built
        on TSMC's CoWoS manufacturing technology, enabling Xilinx to deliver
        devices with 2-4X the capacity of competing devices and continue to stay
        ahead of what Moore's Law could otherwise offer.

Business Outlook - March Quarter Fiscal 2014


    --  Sales are expected to be up 2% to up 6% sequentially.
    --  Gross margin is expected to be approximately 68%.
    --  Operating expenses are expected to be approximately $226 million,
        including $2.5 million of amortization of acquisition-related
        intangibles.
    --  Other income and expenses are expected to be a net expense of
        approximately $7 million.
    --  Fully diluted share count is expected to be approximately 289 million.
    --  March quarter tax rate is expected to be approximately 13%.

Conference Call

A conference call will be held today at 2:00 p.m. Pacific Time to discuss the December quarter financial results and management's outlook for the March quarter. The webcast and subsequent replay will be available in the Investor Relations section of the Company's web site at www.investor.xilinx.com. A telephonic replay of the call may be accessed later in the day by calling (855) 859-2056 and referencing confirmation code 30665781. The telephonic replay will be available for two weeks following the live call.

This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as "expect," "believe," "may," "will," "could," "anticipate," "estimate," "continue," "plan," "intend," "project" or other similar expressions. Statements that refer to or are based on projections, uncertain events or assumptions also identify forward-looking statements. Such forward looking statements include, but are not limited to, statements related to the semiconductor market, the growth and acceptance of our products, expected revenue growth, the demand and growth in the markets we serve, opportunity for expansion into new markets, and our expectations regarding our business outlook for the March quarter of fiscal 2014. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including customer acceptance of our new products, current global economic conditions, the health of our customers and the end markets in which they participate, our ability to forecast end customer demand, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, costs and liabilities associated with current and future litigation, and other risk factors listed in our most recent Forms 10-Q and 10-K.

About Xilinx

Xilinx develops All Programmable technologies and devices, beyond hardware to software, digital to analog, and single to multiple die in 3D ICs. These industry leading devices are coupled with a next-generation design environment and IP to serve a broad range of customer needs, from programmable logic to programmable systems integration. For more information visit www.xilinx.com.

#1403F

Xilinx, the Xilinx logo, Artix, ISE, Kintex, Spartan, Virtex, Zynq, Vivado, and other designated brands included herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.

XLNX-F


    XILINX, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF INCOME
    (Unaudited)
    (In thousands, except per share amounts)

                                                Three Months Ended                                Nine Months Ended
                                                ------------------


                                                            December 28, 2013  September 28, 2013                   December 29, 2012          December 28, 2013 December 29, 2012
                                                            -----------------  ------------------                   -----------------          ----------------- -----------------

    Net revenues                                                     $586,816            $598,937                                     $509,767        $1,764,708                   $1,636,484

    Cost of
     revenues                                                         180,792             182,816                                      170,493           543,308                      556,617
                                                                      -------             -------                                      -------           -------                      -------

    Gross margin                                                      406,024             416,121                                      339,274         1,221,400                    1,079,867
                                                                      -------             -------                                      -------         ---------                    ---------

    Operating expenses:

       Research and
        development                                                   128,092             125,002                                      129,055           364,635                      364,389

       Selling,
        general and
        administrative                                                 91,794              96,339                                       86,823           280,520                      274,952

       Amortization
        of
        acquisition-
        related
        intangibles                                                     2,589               2,418                                        2,554             7,425                        7,021

       Litigation
        and
        contingencies                                                 (19,190)             28,600                                            -             9,410                            -
                                                                      -------              ------                                          ---             -----                          ---

    Total
     operating
     expenses                                                         203,285             252,359                                      218,432           661,990                      646,362
                                                                      -------             -------                                      -------           -------                      -------


    Operating
     income                                                           202,739             163,762                                      120,842           559,410                      433,505

    Interest and
     other
     expense,
     net                                                                4,807              10,997                                        5,149            25,734                       24,824
                                                                        -----              ------                                        -----            ------                       ------

    Income
     before
     income
     taxes                                                            197,932             152,765                                      115,693           533,676                      408,681

    Provision
     for income
     taxes                                                             22,055              11,304                                       12,045            59,315                       51,765
                                                                       ------              ------                                       ------            ------                       ------

    Net income                                                       $175,877            $141,461                                     $103,648          $474,361                     $356,916
                                                                     ========            ========                                     ========          ========                     ========

    Net income per common share:

       Basic                                                            $0.66               $0.53                                        $0.40             $1.78                        $1.36
                                                                        =====               =====                                        =====             =====                        =====

       Diluted                                                          $0.61               $0.49                                        $0.38             $1.66                        $1.31
                                                                        =====               =====                                        =====             =====                        =====

    Cash
     dividends
     per common
     share                                                              $0.25               $0.25                                        $0.22             $0.75                        $0.66
                                                                        =====               =====                                        =====             =====                        =====

    Shares used in per share calculations:

       Basic                                                          267,780             268,478                                      260,690           266,068                      261,723
                                                                      =======             =======                                      =======           =======                      =======

       Diluted                                                        288,195             290,685                                      271,174           285,380                      271,861
                                                                      =======             =======                                      =======           =======                      =======


    XILINX,
     INC.
    CONDENSED
     CONSOLIDATED
     BALANCE
     SHEETS

    (In
     thousands)


                    December 28, 2013            March 30, 2013 *
                    -----------------             ---------------

                       (unaudited)

    ASSETS

    Current
     assets:

      Cash, cash
       equivalents
       and
       short-
       term
       investments                    $2,457,419                  $1,714,745

      Accounts
       receivable,
       net                               207,248                     229,175

      Inventories                        206,728                     201,250

      Deferred
       tax
       assets
       and other
       current
       assets                             76,431                     152,469

    Total
     current
     assets                            2,947,826                   2,297,639

    Net
     property,
     plant and
     equipment                           354,800                     365,687

    Long-term
     investments                       1,287,392                   1,651,033

    Other
     assets                              411,783                     415,092

    Total
     Assets                           $5,001,801                  $4,729,451
                                      ==========                  ==========



     LIABILITIES
     ,
     TEMPORARY
     EQUITY
     AND
     STOCKHOLDERS'
     EQUITY

    Current
     liabilities:

      Accounts
       payable
       and
       accrued
       liabilities                      $309,009                    $333,379

      Deferred
       income on
       shipments
       to
       distributors                       48,075                      53,358

      Deferred
       tax
       liabilities                       140,601                          51

       Convertible
       debentures                        934,392                           -

    Total
     current
     liabilities                       1,432,077                     386,788

     Convertible
     debentures                                -                     922,666

    Deferred
     tax
     liabilities                         279,696                     415,442

    Other
     long-
     term
     liabilities                          13,057                      41,259

    Temporary
     equity                              355,243                           -

     Stockholders'
     equity                            2,921,728                   2,963,296

    Total
     Liabilities,
     Temporary
     Equity
     and
     Stockholders'
     Equity                           $5,001,801                  $4,729,451
                                      ==========                  ==========


    XILINX, INC.

    SUPPLEMENTAL FINANCIAL INFORMATION

    (Unaudited)

    (In thousands)

                                            Three Months Ended                                    Nine Months Ended
                                            ------------------


                                          December 28, 2013            September 28, 2013                           December 29, 2012         December 28, 2013         December 29, 2012
                                          -----------------            ------------------                           -----------------         -----------------         -----------------

    SELECTED CASH FLOW INFORMATION:

    Depreciation                                               $13,595                    $13,976                                     $13,680                   $41,604                   $42,434

    Amortization                                                 5,058                      4,885                                       4,423                    14,828                    12,878

    Stock-based
     compensation                                               24,339                     23,060                                      19,762                    68,353                    56,616

    Net cash provided by
     operating activities                                      216,390                    254,943                                     122,568                   615,542                   482,884

    Purchases of
     property, plant and
     equipment                                                  10,975                      8,441                                       8,075                    30,717                    24,053

    Payment of dividends
     to stockholders                                            67,096                     67,198                                      57,326                   200,301                   172,647

    Repurchases of common
     stock                                                      97,140                     69,981                                      19,541                   167,121                   197,689

    Proceeds from
     issuance of common
     stock to employees
     and excess tax
     benefit                                                    12,729                    110,925                                      20,547                   157,611                    58,201


    STOCK-BASED COMPENSATION INCLUDED IN:

    Cost of revenues                                            $1,966                     $1,858                                      $1,517                    $5,628                    $4,718

    Research and
     development                                                11,912                     11,343                                       9,654                    33,474                    27,681

    Selling, general and
     administrative                                             10,461                      9,859                                       8,591                    29,251                    24,217

SOURCE Xilinx, Inc.